0001179110-15-001100.txt : 20150121 0001179110-15-001100.hdr.sgml : 20150121 20150121202945 ACCESSION NUMBER: 0001179110-15-001100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150116 FILED AS OF DATE: 20150121 DATE AS OF CHANGE: 20150121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KYTHERA BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001436304 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27200 WEST AGOURA ROAD STREET 2: SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 BUSINESS PHONE: 818-587-4500 MAIL ADDRESS: STREET 1: 27200 WEST AGOURA ROAD STREET 2: SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Samuels Camille D CENTRAL INDEX KEY: 0001354034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35663 FILM NUMBER: 15540035 MAIL ADDRESS: STREET 1: 2463 JACKSON ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94115 4 1 edgar.xml FORM 4 - X0306 4 2015-01-16 0 0001436304 KYTHERA BIOPHARMACEUTICALS INC KYTH 0001354034 Samuels Camille D C/O KYTHERA BIOPHARMACEUTICALS, INC. 30930 RUSSELL RANCH ROAD, SUITE 300 WESTLAKE VILLAGE CA 91362 1 0 0 0 Common Stock 2015-01-16 4 S 0 100 36.22 D 15835 D Common Stock 2015-01-16 4 S 0 150 37.02 D 15685 D The sales reported in this Form 4 were effected pursuant to the Reporting Person's 10b5-1 plan which expires December 31, 2015. Reflects the pro rata distribution of an aggregate of 15,935 shares from Versant Ventures II, LLC to the Reporting Person as follows: 4,519 shares on October 3, 2013, 4,965 shares on October 15, 2013, and 6,451 shares on March 4, 2014. The Reporting Person no longer has beneficial ownership of shares previously reported as indirectly held by Versant Venture Capital II, L.P., Versant Side Fund II, L.P., Versant Affiliates Fund II-A, L.P. and Versant Venture Management LLC. Keith Klein, as Attorney-in-Fact for Camille Samuels 2015-01-21